Status:
UNKNOWN
Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS.
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
ALS (Amyotrophic Lateral Sclerosis)
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This project aims to develop a smart communication system for patients with amyotrophic lateral sclerosis (ALS), especially for stage 3 and stage 4 (late stage). Patients with ALS will be able to comm...
Detailed Description
A multi-function brain- computer interface (BCI) communication system will be developed by combining a BCI system (subproject 1) and a 3D electro-cap (subproject 3). Then, this system and an eye-contr...
Eligibility Criteria
Inclusion
- Part one:
- ALS diagnostic criteria (Brooks et al., 2000).Must have the following characteristics:
- Degeneration of motor neurons (LMN) by clinical, electrophysiological or neuropathological evidence.
- Degeneration of upper motor neurons (UMN) is demonstrated by clinical examination.
- According to the medical history or examination, the symptoms or signs gradually disappear in a certain part.
- Also, there are no features:
- Electrophysiological or pathological evidence of other diseases that may explain signs of LMN and/or UMN degradation
- Neuroimaging evidence of other diseases that may explain the observed clinical electrophysiological signs.
- Use Mandarin as the main language.
- Age limits minimum is 20
Exclusion
- Concomitant other central nervous disorders that interfere with their cognitive function, such as dementia, severe depression, and psychosis.
- The questionnaire cannot be completed without the assistance of others.
- Part two:
- Inclusion Criteria:
- ALS diagnostic criteria (Brooks et al., 2000).
- Use Mandarin as the main language.
- Age limits minimum is 20
- In everyday oral communication, people who are consciously difficult.
- Ability to perform equipment wear and system operators.
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03787420
Start Date
September 1 2018
End Date
December 31 2019
Last Update
December 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Center, Taipei Veterans General Hospital
Taipei, Taiwan, 11217